# Lansoprazole Versus Mosapride for Functional Dyspepsia

> **NCT00663897** · PHASE4 · COMPLETED · sponsor: **Lotung Poh-Ai Hospital** · enrollment: 329 (actual)

## Conditions studied

- Functional Dyspepsia
- Epigastric Pain Syndrome
- Post Prandial Distress Syndrome

## Interventions

- **DRUG:** lansoprazole
- **DRUG:** mosapride

## Key facts

- **NCT ID:** NCT00663897
- **Lead sponsor:** Lotung Poh-Ai Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2009-07
- **Final completion:** 2009-09
- **Target enrollment:** 329 (ACTUAL)
- **Last updated:** 2009-10-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00663897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00663897, "Lansoprazole Versus Mosapride for Functional Dyspepsia". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00663897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*